Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Blank

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 8, 2014
Risk factors for AA amyloidosis in GermanyNorbert Blank, Ute Hegenbart, Peter Lohse, et al.
International Immunology|March 4, 2008
Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergyMartin A Kriegel, Sabine Adam-Klages, Christoph Gabler, et al.
European Journal of Immunology|May 1, 2002
Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosisHanns-Martin Lorenz, Mathias Grünke, Thomas Hieronymus, et al.
Frontiers in Immunology|November 30, 2018
Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting GlutathioneJie Liang, Beate Jahraus, Emre Balta, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 4, 2010
[In Process Citation]Christoph Fiehn, Regina Max, Norbert Blank, et al.
Annals of the Rheumatic Diseases|June 1, 2025
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel diseaseHanns-Martin Lorenz, Wolfgang Merkt, Juliane Brandt, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2018
Obesity is a significant susceptibility factor for idiopathic AA amyloidosisNorbert Blank, Ute Hegenbart, Sascha Dietrich, et al.
Frontiers in Immunology|March 31, 2018
Extracellular Vesicle Subtypes Released From Activated or Apoptotic T-Lymphocytes Carry a Specific and Stimulus-Dependent Protein CargoChristine Tucher, Konrad Bode, Petra Schiller, et al.
Zeitschrift Fur Rheumatologie|July 25, 2024
[Interdisciplinary centers for autoimmune diseases in Germany]Margitta Worm, Claudia Günther, Martin Claussen, et al.
Arthritis and Rheumatism|June 26, 2008
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosusRam Kumar Chowdary Venigalla, Theresa Tretter, Stefan Krienke, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 8, 2014
Risk factors for AA amyloidosis in GermanyNorbert Blank, Ute Hegenbart, Peter Lohse, et al.
International Immunology|March 4, 2008
Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergyMartin A Kriegel, Sabine Adam-Klages, Christoph Gabler, et al.
European Journal of Immunology|May 1, 2002
Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosisHanns-Martin Lorenz, Mathias Grünke, Thomas Hieronymus, et al.
Frontiers in Immunology|November 30, 2018
Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting GlutathioneJie Liang, Beate Jahraus, Emre Balta, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 4, 2010
[In Process Citation]Christoph Fiehn, Regina Max, Norbert Blank, et al.
Annals of the Rheumatic Diseases|June 1, 2025
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel diseaseHanns-Martin Lorenz, Wolfgang Merkt, Juliane Brandt, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2018
Obesity is a significant susceptibility factor for idiopathic AA amyloidosisNorbert Blank, Ute Hegenbart, Sascha Dietrich, et al.
Frontiers in Immunology|March 31, 2018
Extracellular Vesicle Subtypes Released From Activated or Apoptotic T-Lymphocytes Carry a Specific and Stimulus-Dependent Protein CargoChristine Tucher, Konrad Bode, Petra Schiller, et al.
Zeitschrift Fur Rheumatologie|July 25, 2024
[Interdisciplinary centers for autoimmune diseases in Germany]Margitta Worm, Claudia Günther, Martin Claussen, et al.
Arthritis and Rheumatism|June 26, 2008
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosusRam Kumar Chowdary Venigalla, Theresa Tretter, Stefan Krienke, et al.
Pageof 11